Operating Lease, Right-of-Use Asset of AbbVie Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AbbVie Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • AbbVie Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $723,000,000, a 2.8% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AbbVie Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $723,000,000 -$21,000,000 -2.8% 31 Dec 2024 10-K 14 Feb 2025 2024 FY
Q4 2023 $744,000,000 +$7,000,000 +0.95% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q4 2022 $737,000,000 -$25,000,000 -3.3% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q4 2021 $762,000,000 -$133,000,000 -15% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q4 2020 $895,000,000 31 Dec 2020 10-K 18 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.